Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi–Bickel Syndrome

Fanconi–Bickel Syndrome (FBS) is a rare disorder of carbohydrate metabolism that is characterized by the accumulation of glycogen mainly in the liver. It is inherited in an autosomal recessive manner due to mutations in the <i>SLC2A2</i> gene. <i>SLC2A2</i> encodes for the gl...

Full description

Bibliographic Details
Main Authors: Sanaa Sharari, Basirudeen Kabeer, Idris Mohammed, Basma Haris, Igor Pavlovski, Iman Hawari, Ajaz Ahmad Bhat, Mohammed Toufiq, Sara Tomei, Rebecca Mathew, Najeeb Syed, Sabah Nisar, Selma Maacha, Jean-Charles Grivel, Damien Chaussabel, Johan Ericsson, Khalid Hussain
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/9/2114
_version_ 1797490979506225152
author Sanaa Sharari
Basirudeen Kabeer
Idris Mohammed
Basma Haris
Igor Pavlovski
Iman Hawari
Ajaz Ahmad Bhat
Mohammed Toufiq
Sara Tomei
Rebecca Mathew
Najeeb Syed
Sabah Nisar
Selma Maacha
Jean-Charles Grivel
Damien Chaussabel
Johan Ericsson
Khalid Hussain
author_facet Sanaa Sharari
Basirudeen Kabeer
Idris Mohammed
Basma Haris
Igor Pavlovski
Iman Hawari
Ajaz Ahmad Bhat
Mohammed Toufiq
Sara Tomei
Rebecca Mathew
Najeeb Syed
Sabah Nisar
Selma Maacha
Jean-Charles Grivel
Damien Chaussabel
Johan Ericsson
Khalid Hussain
author_sort Sanaa Sharari
collection DOAJ
description Fanconi–Bickel Syndrome (FBS) is a rare disorder of carbohydrate metabolism that is characterized by the accumulation of glycogen mainly in the liver. It is inherited in an autosomal recessive manner due to mutations in the <i>SLC2A2</i> gene. <i>SLC2A2</i> encodes for the glucose transporter GLUT2 and is expressed in tissues that are involved in glucose homeostasis. The molecular mechanisms of dysglycemia in FBS are still not clearly understood. In this study, we report two cases of FBS with classical phenotypes of FBS associated with dysglycemia. Genomic DNA was extracted and analyzed by whole-genome and Sanger sequencing, and patient PBMCs were used for molecular analysis. One patient had an exonic <i>SLC2A2</i> mutation (c.1093C>T in exon 9, R365X), while the other patient had a novel intronic <i>SLC2A2</i> mutation (c.613-7T>G). Surprisingly, the exonic mutation resulted in the overexpression of dysfunctional GLUT2, resulting in the dysregulated expression of other glucose transporters. The intronic mutation did not affect the coding sequence of GLUT2, its expression, or glucose transport activity. However, it was associated with the expression of miRNAs correlated with type 1 diabetes mellitus, with a particular significant overexpression of hsa-miR-29a-3p implicated in insulin production and secretion. Our findings suggest that <i>SLC2A2</i> mutations cause dysglycemia in FBS either by a direct effect on GLUT2 expression and/or activity or, indirectly, by the dysregulated expression of miRNAs implicated in glucose homeostasis.
first_indexed 2024-03-10T00:40:49Z
format Article
id doaj.art-fdc507a460194407a6173afa34a196b8
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T00:40:49Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-fdc507a460194407a6173afa34a196b82023-11-23T15:09:21ZengMDPI AGBiomedicines2227-90592022-08-01109211410.3390/biomedicines10092114Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi–Bickel SyndromeSanaa Sharari0Basirudeen Kabeer1Idris Mohammed2Basma Haris3Igor Pavlovski4Iman Hawari5Ajaz Ahmad Bhat6Mohammed Toufiq7Sara Tomei8Rebecca Mathew9Najeeb Syed10Sabah Nisar11Selma Maacha12Jean-Charles Grivel13Damien Chaussabel14Johan Ericsson15Khalid Hussain16Division of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha 34110, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarDivision of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha 34110, QatarDepartment of Pediatric Medicine, Division of Endocrinology, Sidra Medicine, Doha 26999, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarDivision of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha 34110, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarResearch Branch, Sidra Medicine, Doha 26999, QatarDivision of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha 34110, QatarDepartment of Pediatric Medicine, Division of Endocrinology, Sidra Medicine, Doha 26999, QatarFanconi–Bickel Syndrome (FBS) is a rare disorder of carbohydrate metabolism that is characterized by the accumulation of glycogen mainly in the liver. It is inherited in an autosomal recessive manner due to mutations in the <i>SLC2A2</i> gene. <i>SLC2A2</i> encodes for the glucose transporter GLUT2 and is expressed in tissues that are involved in glucose homeostasis. The molecular mechanisms of dysglycemia in FBS are still not clearly understood. In this study, we report two cases of FBS with classical phenotypes of FBS associated with dysglycemia. Genomic DNA was extracted and analyzed by whole-genome and Sanger sequencing, and patient PBMCs were used for molecular analysis. One patient had an exonic <i>SLC2A2</i> mutation (c.1093C>T in exon 9, R365X), while the other patient had a novel intronic <i>SLC2A2</i> mutation (c.613-7T>G). Surprisingly, the exonic mutation resulted in the overexpression of dysfunctional GLUT2, resulting in the dysregulated expression of other glucose transporters. The intronic mutation did not affect the coding sequence of GLUT2, its expression, or glucose transport activity. However, it was associated with the expression of miRNAs correlated with type 1 diabetes mellitus, with a particular significant overexpression of hsa-miR-29a-3p implicated in insulin production and secretion. Our findings suggest that <i>SLC2A2</i> mutations cause dysglycemia in FBS either by a direct effect on GLUT2 expression and/or activity or, indirectly, by the dysregulated expression of miRNAs implicated in glucose homeostasis.https://www.mdpi.com/2227-9059/10/9/2114Fanconi–Bickel syndrome (FBS)dysglycemiaglucose transporter 2 (GLUT2)PBMCs (peripheral blood mononuclear cells)miRNAs
spellingShingle Sanaa Sharari
Basirudeen Kabeer
Idris Mohammed
Basma Haris
Igor Pavlovski
Iman Hawari
Ajaz Ahmad Bhat
Mohammed Toufiq
Sara Tomei
Rebecca Mathew
Najeeb Syed
Sabah Nisar
Selma Maacha
Jean-Charles Grivel
Damien Chaussabel
Johan Ericsson
Khalid Hussain
Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi–Bickel Syndrome
Biomedicines
Fanconi–Bickel syndrome (FBS)
dysglycemia
glucose transporter 2 (GLUT2)
PBMCs (peripheral blood mononuclear cells)
miRNAs
title Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi–Bickel Syndrome
title_full Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi–Bickel Syndrome
title_fullStr Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi–Bickel Syndrome
title_full_unstemmed Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi–Bickel Syndrome
title_short Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi–Bickel Syndrome
title_sort understanding the role of glut2 in dysglycemia associated with fanconi bickel syndrome
topic Fanconi–Bickel syndrome (FBS)
dysglycemia
glucose transporter 2 (GLUT2)
PBMCs (peripheral blood mononuclear cells)
miRNAs
url https://www.mdpi.com/2227-9059/10/9/2114
work_keys_str_mv AT sanaasharari understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT basirudeenkabeer understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT idrismohammed understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT basmaharis understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT igorpavlovski understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT imanhawari understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT ajazahmadbhat understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT mohammedtoufiq understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT saratomei understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT rebeccamathew understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT najeebsyed understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT sabahnisar understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT selmamaacha understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT jeancharlesgrivel understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT damienchaussabel understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT johanericsson understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome
AT khalidhussain understandingtheroleofglut2indysglycemiaassociatedwithfanconibickelsyndrome